Report Indonesia - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Indonesia - Vaccines for Human Medicine - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Indonesia: Vaccine Market 2024

Vaccine Market Size in Indonesia

The Indonesian vaccine market totaled $X in 2022, surging by 3.8% against the previous year. Over the period under review, consumption continues to indicate resilient growth. Over the period under review, the market hit record highs at $X in 2020; afterwards, it flattened through to 2022.

Vaccine Production in Indonesia

In value terms, vaccine production stood at $X in 2022 estimated in export price. Over the period under review, production posted buoyant growth. The growth pace was the most rapid in 2018 when the production volume increased by 48%. Vaccine production peaked at $X in 2020; afterwards, it flattened through to 2022.

Vaccine Exports

Exports from Indonesia

In 2022, the amount of vaccines for human medicine exported from Indonesia declined to X tons, with a decrease of -14.7% against the previous year. Overall, exports saw a noticeable descent. The most prominent rate of growth was recorded in 2015 with an increase of 60% against the previous year. As a result, the exports attained the peak of X tons. From 2016 to 2022, the growth of the exports remained at a lower figure.

In value terms, vaccine exports reduced dramatically to $X in 2022. Over the period under review, exports recorded a relatively flat trend pattern. The most prominent rate of growth was recorded in 2021 with an increase of 48%. The exports peaked at $X in 2015; however, from 2016 to 2022, the exports remained at a lower figure.

Exports by Country

India (X tons) was the main destination for vaccine exports from Indonesia, with a 53% share of total exports. Moreover, vaccine exports to India exceeded the volume sent to the second major destination, Nigeria (X tons), fourfold. Pakistan (X tons) ranked third in terms of total exports with a 7.3% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to India totaled -5.0%. Exports to the other major destinations recorded the following average annual rates of exports growth: Nigeria (+2.9% per year) and Pakistan (+33.9% per year).

In value terms, India ($X) remains the key foreign market for vaccines for human medicine exports from Indonesia, comprising 47% of total exports. The second position in the ranking was held by Nigeria ($X), with a 19% share of total exports. It was followed by Pakistan, with a 10% share.

From 2012 to 2022, the average annual rate of growth in terms of value to India amounted to -2.8%. Exports to the other major destinations recorded the following average annual rates of exports growth: Nigeria (+8.6% per year) and Pakistan (+48.8% per year).

Export Prices by Country

In 2022, the average vaccine export price amounted to $X per ton, waning by -1.8% against the previous year. Over the last decade, it increased at an average annual rate of +3.0%. The most prominent rate of growth was recorded in 2016 an increase of 35%. Over the period under review, the average export prices reached the maximum at $X per ton in 2021, and then fell modestly in the following year.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Afghanistan ($X per ton), while the average price for exports to Mali ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Pakistan (+11.2%), while the prices for the other major destinations experienced more modest paces of growth.

Vaccine Imports

Imports into Indonesia

In 2022, imports of vaccines for human medicine into Indonesia fell modestly to X tons, shrinking by -4.2% on the previous year. In general, imports, however, showed a resilient expansion. The pace of growth appeared the most rapid in 2017 with an increase of 126% against the previous year. Over the period under review, imports attained the maximum at X tons in 2020; however, from 2021 to 2022, imports remained at a lower figure.

In value terms, vaccine imports dropped to $X in 2022. Over the period under review, imports, however, recorded strong growth. The growth pace was the most rapid in 2017 when imports increased by 120%. Imports peaked at $X in 2021, and then declined in the following year.

Imports by Country

In 2022, China (X tons) constituted the largest supplier of vaccine to Indonesia, accounting for a 35% share of total imports. Moreover, vaccine imports from China exceeded the figures recorded by the second-largest supplier, the United States (X tons), twofold. India (X tons) ranked third in terms of total imports with an 8.5% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from China stood at +203.2%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (+68.9% per year) and India (+48.1% per year).

In value terms, China ($X) constituted the largest supplier of vaccines for human medicine to Indonesia, comprising 61% of total imports. The second position in the ranking was held by the United States ($X), with an 8.9% share of total imports. It was followed by the Netherlands, with a 4.3% share.

From 2012 to 2022, the average annual rate of growth in terms of value from China stood at +283.0%. The remaining supplying countries recorded the following average annual rates of imports growth: the United States (+75.4% per year) and the Netherlands (+17.7% per year).

Import Prices by Country

In 2022, the average vaccine import price amounted to $X per ton, with a decrease of -3.4% against the previous year. Overall, import price indicated a moderate expansion from 2012 to 2022: its price increased at an average annual rate of +4.0% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, vaccine import price increased by +39.0% against 2020 indices. The most prominent rate of growth was recorded in 2021 an increase of 44% against the previous year. As a result, import price reached the peak level of $X per ton, and then shrank modestly in the following year.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was China ($X per ton), while the price for Thailand ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by China (+26.3%), while the prices for the other major suppliers experienced mixed trend patterns.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The countries with the highest volumes of vaccines consumption in 2020 were China, the United States and Japan, with a combined 44% share of global consumption. India, Germany, Russia, Nigeria, Indonesia, the Netherlands, Mexico, France, Pakistan and Canada lagged somewhat behind, together accounting for a further 32%.
The countries with the highest volumes of vaccines production in 2020 were Ireland, China and the United States, with a combined 46% share of global production.
In value terms, the largest vaccines suppliers to Indonesia were China, Hong Kong SAR and the United States, together accounting for 59% of total imports.
In value terms, India remains the key foreign market for vaccines exports from Indonesia, comprising 51% of total exports. The second position in the ranking was occupied by Pakistan, with a 22% share of total exports. It was followed by Afghanistan, with a 3.4% share.
In 2020, the average vaccines export price amounted to $130,732 per ton, surging by 7.4% against the previous year.
In 2020, the average vaccines import price amounted to $290,068 per ton, dropping by -37.6% against the previous year.

This report provides an in-depth analysis of the vaccine market in Indonesia. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21202140 -
  • Prodcom 21202145 - Vaccines for human medicine

Country coverage:

  • Indonesia

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Indonesia
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Free Data: Vaccines For Human Medicine - Indonesia